04041nam 22005775 450 991025455600332120200630035614.03-319-30964-110.1007/978-3-319-30964-4(CKB)3710000000718118(DE-He213)978-3-319-30964-4(MiAaPQ)EBC4533863(PPN)19407921X(EXLCZ)99371000000071811820160528d2016 u| 0engurnn|008mamaatxtrdacontentcrdamediacrrdacarrierControlled Substance Management in Chronic Pain A Balanced Approach /edited by Peter S. Staats, Sanford M. Silverman1st ed. 2016.Cham :Springer International Publishing :Imprint: Springer,2016.1 online resource (XII, 323 p. 32 illus., 18 illus. in color.) 3-319-30962-5 Includes bibliographical references at the end of each chapters and index.1 Scope of the pain problem -- 2 Scope of the problem: Intersection of chronic pain and addiction -- 3 Evidence-based treatment for chronic pain with opioids -- 4 Opioid pharmacology -- 5 Pharmacokinetics -- 6 Benzodiazepines, Alcohol and Stimulant Use in Combination with Opioid Use -- 7 Marijuana and cannabinoids for pain -- 8 Adjuvant agents in chronic pain therapy -- 9 Complications of opioid therapy -- 10 Risk mitigation strategies -- 11 Naloxone Treatment of Opioid Overdose -- 12 From Patient Evaluation to Opioid Overdose Prevention: Ten Steps to Make the Law Work for You and Your Patients -- 13 Treating the difficult patient -- 14 Controlled Substance Management: Exit Strategies for the Pain Practitioner -- 15 Alternatives to opiates in the management of non-cancer related pain -- Appendix A: American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain -- Appendix B: Sample Opioid Agreement/Informed Consent -- Appendix C: Opioid Risk Tool -- Appendix D: Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R) -- Appendix E: McGill Pain Questionnaire.This comprehensive guide covers prescribing controlled substances for patients with acute or chronic pain and provides a balanced discussion on appropriate treatment, addiction, safety and complications. Chapters feature evidence-based strategies and clinical modalities that address diagnostic challenges, treatment guidance, alternatives to opioid management and the significant legal risks within the current regulatory environment. Authored by leaders in pain medicine, physicians and appropriate health care professionals will find Controlled Substance Management in Chronic Pain to be an indispensable resource. .Pain medicinePharmacotherapyPharmacy managementPrimary care (Medicine)Pain Medicinehttps://scigraph.springernature.com/ontologies/product-market-codes/H47003Pharmacotherapyhttps://scigraph.springernature.com/ontologies/product-market-codes/H69000Pharmacoeconomics and Health Outcomeshttps://scigraph.springernature.com/ontologies/product-market-codes/H69020Primary Care Medicinehttps://scigraph.springernature.com/ontologies/product-market-codes/H51000Pain medicine.Pharmacotherapy.Pharmacy management.Primary care (Medicine).Pain Medicine.Pharmacotherapy.Pharmacoeconomics and Health Outcomes.Primary Care Medicine.616.0472Staats Peter Sedthttp://id.loc.gov/vocabulary/relators/edtSilverman Sanford Medthttp://id.loc.gov/vocabulary/relators/edtBOOK9910254556003321Controlled Substance Management in Chronic Pain2529653UNINA